Back to Search
DAVID MORROW, MD
MD
Cardiovascular Disease Physician
NPI: 1316928039IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
152630(MA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
HARVARD MEDICAL SCHOOL
Class of 1994
Research & Publications (20)
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
PMID 19451347·Circulation·2009
4-observational
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial.
PMID 18535785·J Thromb Thrombolysis·2009
4-observational
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
PMID 19349325·Circulation·2009
4-observational
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
PMID 18082488·Am Heart J·2008
2-rct
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
PMID 18339606·Eur Heart J·2008
2-rct
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
PMID 18035078·Am Heart J·2007
4-observational
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
PMID 17456819·JAMA·2007
4-observational
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
PMID 17384331·Circulation·2007
6-review
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
PMID 16847150·Circulation·2006
2-rct
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
PMID 16781216·Am Heart J·2006
3-trial
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial.
PMID 15684280·Eur Heart J·2005
3-trial
Brigham and Women's Hospital admission order set for unstable angina/non-ST elevation myocardial infarction.
PMID 18340192·Crit Pathw Cardiol·2005
8-other
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
PMID 16352794·JAMA·2005
4-observational
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies.
PMID 15231372·Eur Heart J·2004
4-observational
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).
PMID 15374786·Am J Cardiol·2004
3-trial
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
PMID 12706919·J Am Coll Cardiol·2003
3-trial
Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.
PMID 12881457·Clin Chem·2003
8-other
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
PMID 11792137·Eur Heart J·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (857) 307-4000
Quick Facts
- NPI
- 1316928039
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile